A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Clinical trial NCT07244341 · RECRUITING
Trial details
- NCT number
- NCT07244341
- Sponsor
- Daiichi Sankyo
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-03
- Primary completion
- 2028-01-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.